Potential risk factors associated with progressive renal damage in childhood urological diseases: The role of angiotensin-converting enzyme gene polymorphism

Journal of Urology

Volumn 158, Issue 3 SUPPL., 1997, Pages 1308-1311

  Brock III, John W ^a   Adams, Mark ^a   Hunley, Trey ^a   Wada, A ^a   Trusler, Lisa ^a   Kon, Valentina ^a  

^a MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

Author keywords

Chromosomes, human; Kidney; Kininase II; Renin angiotensin system

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; DISEASE COURSE; GENETIC DISORDER; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFANT; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR;

EID: 0030803011     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64463-X     Document Type: Article

References (27)

1. Matsusaka T., Hymes J., Ichikawa I.: Angiotensin in progressive renal disease: theory and practice. J. Amer. Soc. Nephrol., in press.
2. Chevalier R.L. Growth factors and apoptosis in neonatal ureteral obstruction. J. Amer. Soc. Nephrol. 7 1996 1098
3. Chevalier R.L. Peach M.J. Hemodynamic effects of enalapril on neonatal partial ureteral obstruction. Kidney Int. 28 1985 1
4. Lewis E.J. Hunsicker L.G. Bain R.P. Rohde R.D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. Collaborative Study Group. New Engl. J. Med. 329 1993 1456
5. Smellie J.M. Normand I.C.S. Reflux nephropathy in childhood. J. Hodson P. Kincaid-Smith Reflux Nephropathy 1979 Masson Publishing New York 14 20 chapt. 2
6. Foreman J.W. Chan J.C. Chronic renal failure in infants and children. J. Ped. 113 1988 793
7. Cambien F. Poirier O. Lecerf L. Evans A. Cambou J.P. Arveiler D. Luc G. Bard J.M. Bara L. Richard S. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359 1992 641
8. Schunkert H. Hense H.W. Holmer S.R. Stender M. Perz S. Keil U. Lorell B.H. Riegger G.A. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. New Engl. J. Med. 330 1994 1634
9. Hunley T.E. Julian B.A. Phillips J.A. III Summar M.L. Yoshida H. Horn R.G. Brown N.J. Fogo A. Ichikawa I. Kon V. Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int. 49 1996 571
10. Doria A. Warram J.H. Krolewski A.S. Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin 1-converting enzyme gene. Diabetes 43 1994 690
11. Yoshida H. Mitarai T. Kawamura T. Kitajima T. Miyazaki Y. Nagasawa R. Kawaguchi Y. Kubo H. Ichikawa I. Sakai O. Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J. Clin. Invest. 96 1995 2162
12. Yoshida H. Kuriyama Y. Atsumi Y. Tomonari H. Mitarai T. Hamaguchi A. Kubo H. Kawaguchi Y. Kon V. Matsuoka K. Sakai O. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int. 50 1996 657
13. Harden P.N. Geddes C. Rowe P.A. McIlroy J.H. Boulton-Jones M. Stuart R. Rodger C. Junor B.J.R. Briggs J.D. Connell J.M. Jardine A.G. Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 345 1995 1540
14. Rutledge D.R. Browe C.S. Ross E.A. Frequencies of the angiotensinogen gene and angiotensin I converting enzyme (ACE) gene polymorphisms in African Americans. Biochem. Molec. Biol. Int. 34 1994 1271
15. Vnencak-Jones C.L. Phillips J.A. III Wang D.F. Use of polymerase chain reaction in detection of growth hormone gene deletions. J. Clin. Endocr. Metab. 70 1990 1550
16. Shanmugam V. Sell K.W. Saha B.K. Mistyping ACE heterozygotes. PCR Meth. Applic. 3 1993 120
17. Fogarty D.G. Maxwell A.P. Doherty C.C. Hughes A.E. Nevin N.C. ACE genotyping. Letter to the Editor. Lancet 343 1994 851
18. Kupari M. Perola M. Koskinen P. Virolainen J. Karhunen P.J. Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Amer. J. Physiol. 267 1994 H1107 part 2
19. Rigat B. Hubert C. Alhenc-Gelas F. Cambien F. Corvol P. Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86 1990 1343
20. Ueda S. Elliott H.L. Morton J.J. Connell J.M. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 25 1995 1266
21. Allan D.R. McKnight J.A. Kifor I. Coletti C.M. Hollenberg N.K. Converting enzyme inhibition and renal tissue angiotensin II in the rat. Hypertension 24 1994 516
22. Liebermann J. Sastre A. Serum angiotensin-converting enzyme: elevations in diabetes mellitus. Ann. Int. Med. 93 1980 825
23. Hallab M. Bled F. Ebran J.M. Suraniti S. Girault A. Fressinaud P. Marre M. Elevated serum angiotensin converting enzyme activity in type I, insulin dependent diabetic subjects with persistent microalbuminuria. Acta Diabetol. 29 1992 82
24. Feriozzi S. Pierucci A. Roscia E. Cinotti G.A. Pecci G. Angiotensin converting enzyme inhibition delays the progression of chronic renal failure in hypertensive patients with immunoglobulin A nephropathy. J. Hypertens. 7 suppl. 1989 S63
25. Cattran D.C. Greenwood C. Ritchie S. Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Amer. J. Kidney Dis. 23 1994 247
26. Dahlof B. Pennert K. Hansson L. Regression of left ventricular hypertrophy-a meta-analysis. Clin. Exp. Hypertens. 14 1992 173 part A
27. Kagami S. Border W.A. Miller D.E. Noble N.A. Angiotensin II stimulates matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J. Clin. Invest. 93 1994 2431